Tech Company Financing Transactions
Kytopen Funding Round
On 5/29/2019, Kytopen landed $3.6 million in Seed funding from Horizons Ventures, The Engine and private investors.
Transaction Overview
Company Name
Announced On
5/29/2019
Transaction Type
Venture Equity
Amount
$3,600,000
Round
Seed
Investors
The Engine (Katie Rae)
Proceeds Purpose
The new investment will power the ongoing development of Flowfect which will enable new discoveries in biology and cost-effective cell therapy manufacturing.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
501 Massachusetts Ave. The Engine Ecosystem
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Kytopen is an MIT startup developing their proprietary Flowfect technology for non-viral delivery of molecules into hard-to-transfect immune cells. The scalable Flowfect technology combines microfluidics and automation to make this process easier, faster, and cheaper than ever before.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paulo Garcia
Chief Operating Officer
Michael Elliott
Co-Founder
Cullen Buie
VP - Bus. Development
Gregory Crescenzi
VP - Engineering
Norman Wen
VP - R & D
Bethany Grant
Browse more venture capital transactions:
Prev: 5/29/2019: DataArt Enterprises venture capital transaction
Next: 5/29/2019: PayJoy venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs